Melanoma
Conference Coverage
Germline testing in advanced cancer can lead to targeted treatment
In a study of nearly 12,000 cancer patients, 7%-9% of patients had targetable germline alterations.
News
Oncologists’ income and satisfaction are up
Conference Coverage
Video coaching may relieve anxiety and distress for long-distance cancer caregivers
Conference Coverage
ASCO goes ahead online, as conference center is used as hospital
From the Journals
COVID-19 death rate was twice as high in cancer patients in NYC study
The overall case fatality rate was 28% for cancer patients with COVID-19 and 14% for noncancer COVID-19 patients.
Feature
Cancer screening, monitoring down during pandemic
Use of some tests came to “a near standstill” in early April.
From the Journals
Excess cancer deaths predicted as care is disrupted by COVID-19
Feature
ASCO panel outlines cancer care challenges during COVID-19 pandemic
Feature
Will coronavirus restrictions lead to more advanced cancers?
From the Journals
European cancer centers restructure care in the era of COVID-19
From the Journals
Want to keep cancer patients and providers safe during the pandemic? Here’s how
Prescreening, telemedicine, and limited interventions top the list of best practices for patients, while PPE, telecommuting, and wellness/stress...